UV/Visible Spectroscopy Market analysis report figures out the market landscape, brand awareness, latest trends, possible future issues, industry trends and customer behaviour so that the business can stand high in the crowd.
To bestow clients with the best results, UV/Visible Spectroscopy Market research report is produced by using integrated approaches and the latest technology.Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=713364Major players:Shimadzu Corporation (Japan),Agilent Technologies (US),Thermo Fisher Scientific, Inc. (US),PerkinElmer, Inc. (US).,Bio-Rad Laboratories, Inc. (US),Bruker Corporation (US),Hach Company (US),Hitachi High-Technologies Corporation (Japan),HORIBA., Ltd (Japan),Mettler-Toledo (Switzerland),Hamamatsu Photonics KK (Japan),Cole-Parmer (UK),Analytik Jena (Germany),GBC Scientific Equipment (US),JASCO Inc. (US),Buck Scientific (US),Biochrom Ltd (UK),AMETEK Process,PG Instruments Ltd (UK)and PERSEE ANALYTICS, Inc (US).The global UV/visible spectroscopy market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020 at a CAGR of 4.7%.Growth in UV/visible Spectroscopy market is mainly driven by factors such as application of UV/visible spectroscopy in environmental screening, growing use of UV/visible spectroscopy in pharmaceutical & biotechnology industry, technological advancements and increasing need for food analysis.Breakdown of supply-side primary interviews:By Company Type: Tier 1 – 74%, Tier 2 – 17%, and Tier 3 – 9%By Designation: C-level – 23%, Director-level – 29%, and Others – 48%By Region: North America – 40%, Europe – 29%, APAC – 14, and RoW – 17%“Dual-beam Systems segment is expected to account for the largest share of the UV/visible Spectroscopy instrument type market in 2019.”On the basis of instrument type, the UV/visible Spectroscopy market is segmented into dual-beam systems, single beam systems, array-based systems and handheld systems.
In 2019, the dual-beam systems segment accounted for the largest share of the UV/visible spectroscopy market.
Such advantages offered by dual-beam systems are supporting its increased adoption in the UV/visible spectroscopy market.“Industrial applications segment is expected to grow at the highest CAGR in the global UV/visible Spectroscopy market during the forecast period.
Technological advancements in instrumentation that have enabled high-throughput screening, microvolume sampling, and automation in instrumentation and software integration have also increased the adoption of this analytical technique for industrial applications.“Pharmaceutical and Biotechnology companies is expected to account for the largest share during the forecast period.”Based on end user segment, the market is segmented into Pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries and Environmental testing labs.
The large share of this segment can be attributed to factors like innovations in biotechnology research and increasing focus on pharmaceutical and biotechnology companies to expand their product pipelines.“North America is expected to dominate the UV/visible spectroscopy market during the forecast period.”Geographically, North America is expected to dominate the global the UV/visible spectroscopy market in 2019, while the Asia Pacific region is expected to register the highest CAGR during the forecast period.
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription Devices (Motorized, Non-Motorized), Applications (Musculoskeletal, Post Op, Sports Medicine), Distribution Channel(Hospital, Retail) – Global Forecasts to 2025 The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period.Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=718464Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management of pain.
Moreover, growing awareness about the availability of cost-effective cooling pain relief products and the ease of application of cold pain therapy products are anticipated to accelerate the adoption of these products in the coming years.
However, presence of alternate pain relief products / therapies in the market are likely to hamper the growth of this market.The major players operating in the cold pain therapy market are Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US).The recent COVID-19 global pandemic has also impacted the cold pain therapy market.
Amid covid pandemic, the reduced access to hospital and retail pharmacies, orthopedic clinics and rehabilitation centers effected the sales growth of the cold therapy products.
However, post lockdown the improved access to cold therapy devices through online platforms and the growing number of patients opting for self-medication with over-the-counter cold therapy products including cold gel packs, ointments, and cold sprays, for pain management are some of the key factors likely to drive the long-term growth of the cold pain therapy market.“The OTC products segment to witness the highest growth rate in cold pain therapy market, by product, during the forecast period.”The OTC products segment is expected to witness the highest growth rate during the forecast period.
The rise in the global prevalence of musculoskeletal disorders such as osteoarthritis, back and neck pain , growing geriatric patient population and influx of wide range of cold therapy products for musculoskeletal disorders are some of the factors anticipated to boost the segment growth in the coming years.“The retail pharmacies segment accounted for the largest share of the cold pain therapy , by distribution channel, in 2020”The presence of different types of cold therapy products in the retail pharamcies has played a critical role in expanding the reach to different customers.
The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025.
The growth of the global refurbished medical equipment market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devices, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.
However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth.
(US), US Med-Equip (US), Avante Health Solutions (US), Everx Pvt Ltd. (Australia), Integrity Medical Systems, Inc. (US), Radiology Oncology Systems, Inc. (US), Master Medical Equipment (US), Hilditch Group (UK), Fair Medical Co. Ltd. (Japan), Future Health Concepts (US), US Medical Systems, LLC.
(US), Nationwide Imaging Services (US), Pacific Healthcare Imaging, LLC (US), Venture Medical ReQuip, Inc. (US), Desert Tech Medical Systems (US), Hi Tech International Group, Inc. (US).“The diagnostic segment is expected to hold the highest share in 2019.”Based on application, the refurbished medical equipment market is segmented into diagnostic and therapeutic application segments.
The rising demand for diagnostic imaging procedures, the high price of new medical imaging equipment, a growing number of target diseases, widening application of diagnostic imaging procedures, regulatory approvals in using refurbished medical equipment, low purchasing power in emerging economies, and established & government validated refurbishment processes adopted by major OEMs are factors expected to drive the growth of this market segment in the coming years.“The medical imaging segment is expected to grow at the highest CAGR during the forecast period.”Based on product, the refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.
UV/Visible Spectroscopy Market analysis report figures out the market landscape, brand awareness, latest trends, possible future issues, industry trends and customer behaviour so that the business can stand high in the crowd.
To bestow clients with the best results, UV/Visible Spectroscopy Market research report is produced by using integrated approaches and the latest technology.Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=713364Major players:Shimadzu Corporation (Japan),Agilent Technologies (US),Thermo Fisher Scientific, Inc. (US),PerkinElmer, Inc. (US).,Bio-Rad Laboratories, Inc. (US),Bruker Corporation (US),Hach Company (US),Hitachi High-Technologies Corporation (Japan),HORIBA., Ltd (Japan),Mettler-Toledo (Switzerland),Hamamatsu Photonics KK (Japan),Cole-Parmer (UK),Analytik Jena (Germany),GBC Scientific Equipment (US),JASCO Inc. (US),Buck Scientific (US),Biochrom Ltd (UK),AMETEK Process,PG Instruments Ltd (UK)and PERSEE ANALYTICS, Inc (US).The global UV/visible spectroscopy market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020 at a CAGR of 4.7%.Growth in UV/visible Spectroscopy market is mainly driven by factors such as application of UV/visible spectroscopy in environmental screening, growing use of UV/visible spectroscopy in pharmaceutical & biotechnology industry, technological advancements and increasing need for food analysis.Breakdown of supply-side primary interviews:By Company Type: Tier 1 – 74%, Tier 2 – 17%, and Tier 3 – 9%By Designation: C-level – 23%, Director-level – 29%, and Others – 48%By Region: North America – 40%, Europe – 29%, APAC – 14, and RoW – 17%“Dual-beam Systems segment is expected to account for the largest share of the UV/visible Spectroscopy instrument type market in 2019.”On the basis of instrument type, the UV/visible Spectroscopy market is segmented into dual-beam systems, single beam systems, array-based systems and handheld systems.
In 2019, the dual-beam systems segment accounted for the largest share of the UV/visible spectroscopy market.
Such advantages offered by dual-beam systems are supporting its increased adoption in the UV/visible spectroscopy market.“Industrial applications segment is expected to grow at the highest CAGR in the global UV/visible Spectroscopy market during the forecast period.
Technological advancements in instrumentation that have enabled high-throughput screening, microvolume sampling, and automation in instrumentation and software integration have also increased the adoption of this analytical technique for industrial applications.“Pharmaceutical and Biotechnology companies is expected to account for the largest share during the forecast period.”Based on end user segment, the market is segmented into Pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries and Environmental testing labs.
The large share of this segment can be attributed to factors like innovations in biotechnology research and increasing focus on pharmaceutical and biotechnology companies to expand their product pipelines.“North America is expected to dominate the UV/visible spectroscopy market during the forecast period.”Geographically, North America is expected to dominate the global the UV/visible spectroscopy market in 2019, while the Asia Pacific region is expected to register the highest CAGR during the forecast period.
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription Devices (Motorized, Non-Motorized), Applications (Musculoskeletal, Post Op, Sports Medicine), Distribution Channel(Hospital, Retail) – Global Forecasts to 2025 The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period.Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=718464Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management of pain.
Moreover, growing awareness about the availability of cost-effective cooling pain relief products and the ease of application of cold pain therapy products are anticipated to accelerate the adoption of these products in the coming years.
However, presence of alternate pain relief products / therapies in the market are likely to hamper the growth of this market.The major players operating in the cold pain therapy market are Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US).The recent COVID-19 global pandemic has also impacted the cold pain therapy market.
Amid covid pandemic, the reduced access to hospital and retail pharmacies, orthopedic clinics and rehabilitation centers effected the sales growth of the cold therapy products.
However, post lockdown the improved access to cold therapy devices through online platforms and the growing number of patients opting for self-medication with over-the-counter cold therapy products including cold gel packs, ointments, and cold sprays, for pain management are some of the key factors likely to drive the long-term growth of the cold pain therapy market.“The OTC products segment to witness the highest growth rate in cold pain therapy market, by product, during the forecast period.”The OTC products segment is expected to witness the highest growth rate during the forecast period.
The rise in the global prevalence of musculoskeletal disorders such as osteoarthritis, back and neck pain , growing geriatric patient population and influx of wide range of cold therapy products for musculoskeletal disorders are some of the factors anticipated to boost the segment growth in the coming years.“The retail pharmacies segment accounted for the largest share of the cold pain therapy , by distribution channel, in 2020”The presence of different types of cold therapy products in the retail pharamcies has played a critical role in expanding the reach to different customers.
The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025.
The growth of the global refurbished medical equipment market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devices, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.
However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth.
(US), US Med-Equip (US), Avante Health Solutions (US), Everx Pvt Ltd. (Australia), Integrity Medical Systems, Inc. (US), Radiology Oncology Systems, Inc. (US), Master Medical Equipment (US), Hilditch Group (UK), Fair Medical Co. Ltd. (Japan), Future Health Concepts (US), US Medical Systems, LLC.
(US), Nationwide Imaging Services (US), Pacific Healthcare Imaging, LLC (US), Venture Medical ReQuip, Inc. (US), Desert Tech Medical Systems (US), Hi Tech International Group, Inc. (US).“The diagnostic segment is expected to hold the highest share in 2019.”Based on application, the refurbished medical equipment market is segmented into diagnostic and therapeutic application segments.
The rising demand for diagnostic imaging procedures, the high price of new medical imaging equipment, a growing number of target diseases, widening application of diagnostic imaging procedures, regulatory approvals in using refurbished medical equipment, low purchasing power in emerging economies, and established & government validated refurbishment processes adopted by major OEMs are factors expected to drive the growth of this market segment in the coming years.“The medical imaging segment is expected to grow at the highest CAGR during the forecast period.”Based on product, the refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.